{"id":"W1973096044","doi":"10.1038/onc.2011.539","title":"A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer","year":2011,"lang":"en","type":"article","venue":"Oncogene","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":false,"ca_institutions":"Women's Health Research Institute","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute","keywords":"KRAS; Biology; Oncology; Ovarian cancer; Hazard ratio; Internal medicine; Oncogene; Cancer; microRNA; Cancer research; Biomarker; Targeted therapy; Chemotherapy; Confidence interval; Medicine; Gene; Colorectal cancer; Cell cycle; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001478676,0.0001245403,0.0001625927,0.00004548468,0.00002564837,0.000005938749,0.00009187292,0.0001219467,0.0001231702],"category_scores_gemma":[0.00001120912,0.0001160893,0.00007187185,0.00007507202,0.00004939363,0.000003785335,0.00001846581,0.00002333356,3.775382e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001407117,"about_ca_system_score_gemma":0.0000837011,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008694935,"about_ca_topic_score_gemma":0.00008752157,"domain_scores_codex":[0.9992138,0.00002913658,0.000247875,0.0002767532,0.0000705287,0.0001618818],"domain_scores_gemma":[0.9995639,0.000004708977,0.0001288517,0.0001903884,0.00006581871,0.00004627949],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001342081,0.0001031719,0.004691785,0.00003327238,0.0001000146,0.000002583061,0.0001590068,0.000001873159,0.9899048,0.00004685574,0.0005962502,0.003018295],"study_design_scores_gemma":[0.003427685,0.0001537571,0.04657424,0.00002336226,0.0000178878,0.0000042498,0.00001580267,0.0001183366,0.9407296,0.0006325227,0.008109267,0.0001932997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902142,0.00264953,0.005920326,0.0002511764,0.00007296808,0.0004617698,0.0001981014,0.000004374527,0.0002275837],"genre_scores_gemma":[0.9869007,0.0004015972,0.01175475,0.0002893624,0.00006757134,0.00008167805,0.00004493477,0.00002695003,0.0004324663],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04917522,"threshold_uncertainty_score":0.4733986,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02388902397070122,"score_gpt":0.2798048829803416,"score_spread":0.2559158590096404,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}